Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer ITEM: News

News / 13.1.2022

REMEDIA project

Impact of the exposome on the course of lung diseases.


Press release / 28.1.2022

EMA-funded project on nitrosamines

A joint research project led by Fraunhofer ITEM will shed light on the mutagenicity of N-nitrosamines.

News / 7.1.2022

Project MONO4ERA

Feasibility study of an active-substance-based review system for the environmental risk assessment of veterinary medicinal products.


Press release / 11.1.2022

Position paper by the ESC

Alternative to animal models – advances in medicine through human-relevant disease models.


News / 9.12.2021

Innovative therapies for heart failure

Researchers are calling for more experimental research to help understand multi-organ involvement in chronic heart failure. 


Press release / 8.12.2021

SPRIND challenge

New development pipeline for RNA-based drugs, aimed at accelerating therapeutic approaches targeting viral diseases.

News / 10.12.2021

AI project ELISE

Research project on machine learning in pediatric intensive-care medicine has been awarded the Lower Saxony Health Prize 2021. 

Our services and expertise

Pioneers for sustainable health

Research at Fraunhofer ITEM is focused on human health – and this has been so for more than four decades.

The emphasis is on two aspects: firstly, on protecting health from potentially harmful, in particular airborne substances, be they gases, aerosols, particles, fibers, or nanomaterials, and secondly, on investigating and developing diagnostic and therapeutic approaches, both at the preclinical and clinical levels.

A special focus is on cardiopulmonary research.


Chemical Safety and Assessment


Translational Biomedical Engineering


Personalized Tumor Therapy

Focus of our research

The lung and airways are at the focus of our R&D activities. Furthermore, Fraunhofer ITEM engages in the development and manufacturing of biopharmaceuticals, tumor therapy, and translational biomedical engineering.


Bioinformatics and Digital Health

The Project Group for Bioinformatics improves the analysis of data collected in health research by using novel intelligent methods.


Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0



Day of Immune Research 2021

On "Day of Immune Research“ current topics in the field of immune-mediated diseases will be presented and discussed across disciplines and across institute borders. Current challenges are to be discussed and new solutions shall be jointly developed.
Read more


Training course: In-silico toxicology

This training course will introduce the participants to three different in-silico approaches for estimation of human health toxicological endpoints, namely QSAR models, read-across, and the TTC (threshold of toxicological concern) concept. The application of in-silico approaches in ecotoxicology will not be addressed in this course.
Read more


Fraunhofer CIMD Winter School 2021

The Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD aims to facilitate and simplify education along the 4Ds (Drugs, Diagnostics, Data, Devices) by supporting young scientists. Cooperation between different disciplines is to be encouraged - a prerequisite for the implementation of 4Ds. In addition to various workshops along the 4Ds, the cluster is planning a winter school in Leipzig, which is aimed primarily at doctoral students, young postdocs and project collaborators of the Fraunhofer CIMD.
Read more


BioEM – The Joint Annual Meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association

From September 26 to October 1, 2021, the international conference in the field of bioelectromagnetics "BioEM – The Joint Annual Meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association" will take place in Ghent, Belgium. Researchers from Fraunhofer ITEM will contribute two posters and an oral presentation.
Read more

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of 75 institutes and research institutions of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on cardiopulmonary research, our R&D portfolio includes three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of 394 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.


More information about Fraunhofer ITEM